Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics

NCT03288012 · clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Sanquin Research & Blood Bank Divisions

Collaborators